Jishi Life

Beijing Jishi Life Technology Co., Ltd. was founded in 2016 and is a national high-tech enterprise commercialized from a research team of Peking University. Focusing on solving the problems of precise clinical tumor treatment, it has established three major technology platforms: tumor genetic testing, cell drug screening, and model animals, providing professional precision medical services for medical institutions and patients worldwide. The company has developed multiple core patented technologies, including micro-tumor chips and precision oncology algorithms, which feature high success rates, high accuracy, and short turnaround times, and have enormous application value in tumor mechanism research, clinical medication guidance, and new drug development. Under Jishi Life, Beijing Jishi Medical Laboratory and Beijing Weishanglide Biotechnology Co., Ltd. have been established, providing medical testing and customized model animal services, respectively. Beijing Jishi Medical Laboratory has obtained a medical institution practice license and has passed multiple laboratory inter-laboratory quality assessments organized by the Clinical Testing Center of the Ministry of Health. Weishanglide is the first company in China to provide TALEN/CRISPR-related services and possesses internationally efficient gene knock-in technology. Since its establishment, the company's business has covered nearly 200 tertiary hospitals in more than 20 provinces across the country, forming a marketing network with the Beijing headquarters as the R&D and operations center and sales regions radiating across Northeast, Northwest, North, Central, East, South, and Southwest China and other regions. Working hand in hand with clients, it has made outstanding progress in tumor heterogeneity, drug target research, and model animal construction, applied for 15 invention patents, and co-published more than 30 papers in internationally renowned journals. The company will always adhere to the corporate philosophy of "Precision Cornerstone, Decoding Life," closely cooperate with research institutes and medical institutions in translational medicine, further develop new precision diagnosis and treatment solutions, and provide integrated precision medicine solutions for customers while promoting the improvement of public health.